Using the instrumental variables estimator to analyze noninferiority trials with noncompliance

Journal of Biopharmaceutical Statistics

Volumn 20, Issue 4, 2010, Pages 745-758

  Kim, Mimi Y ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Instrumental variables estimator; Noncompliance; Noninferiority trial

Indexed keywords

ANALYTIC METHOD; ANALYTICAL ERROR; ARTICLE; CAUSAL ATTRIBUTION; CLINICAL EFFECTIVENESS; CLINICAL PROTOCOL; CLINICAL STUDY; HUMAN; INTENT TO TREAT; NONINFERIORITY STUDY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; SAMPLE SIZE; STANDARD; STATISTICAL ANALYSIS; STATISTICAL MODEL; THERAPY;

ALGORITHMS; AMOXICILLIN; BIAS (EPIDEMIOLOGY); CHILD; DOUBLE-BLIND METHOD; HUMANS; MEDICATION ADHERENCE; MODELS, STATISTICAL; OTITIS; PROBABILITY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SAMPLE SIZE; TREATMENT OUTCOME; TREATMENT REFUSAL;

EID: 77952919279     PISSN: 10543406     EISSN: 15205711     Source Type: Journal    
DOI: 10.1080/10543401003618157     Document Type: Article

References (19)

1. Angrist, J., Imbens, G. (1995). Identification and two-stage least squares estimation of average causal effects in models with variable treatment intensity. Journal of the American Statistical Association 90:431-442.
2. Angrist, J., Imbens, G., Rubin, D. (1996). Identification of causal effects using instrumental variables. Journal of the American Statistical Association 91:444-455. (Pubitemid 126412813)
3. Buyon, J., Petri, M., Kim, M., Kalunian, K., Grossman, J., Hahn, B., Merrill, J., Sammaritano, L., Lockshin, M., Alarcon, G., Manzi, S., Belmont, H., Askanase, A., Sigler, L., Dooley, M., Von Feldt, J., McCune, W., Friedman, A., Wachs, J., Cronin, M., Hearth-Holmes, M., Tan, M., Licciardi, F. (2005). The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial. Annals of Internal Medicine 142:953-962.
4. Cuzick, J., Edwards, R., Segnan, N. (1997). Adjusting for non-compliance and contamination in randomized clinical trials. Statistics in Medicine 16:1017-1029.
5. Dunn, G. (2005). Estimating treatment effects from randomized clinical trials with noncompliance and loss to follow-up: the role of instrumental variable methods. Statistical Methods in Medical Research 14:369-395.
6. Garrett, A. (2003). Therapeutic equivalence: Fallacies and falsification. Statistics in Medicine 22:741-762.
7. Greenland, S. (2000). An introduction to instrumental variables for epidemiologists. International Journal of Epidemiology 29:722-729.
8. Hauck, W., Anderson, S. (1999). Some issues in the design and analysis of equivalence trials. Drug Information Journal 33:109-118.
9. Le Saux, N., Gaboury, I., Baird, M., Klassen, T., MacCormick, J., Blanchard, C., Pitters, C., Sampson, M., Moher, D. (2005). A randomized, double-blind, placebo-controlled noninferiority trial of amoxicillin for clinically diagnosed acute otitis media in children 6 months to 5 years of age. Canadian Medical Association Journal 172:335-341.
10. Little, R., Rubin, D. (2000). Causal effects in clinical and epidemiological studies via potential outcomes: Concepts and analytic approaches. Annual Review of Public Health 21:121-145.
11. Lui, K., Chang, K. (2008). Sample size determination for assessing equivalence based on proportion ratio under a randomized trial with non-compliance and missing outcomes. Statistics in Medicine 27:47-67.
12. McIntosh, M. (1999). Instrumental variables when evaluating screening trials: estimating the benfit of detecting cancer by screening. Statistics in Medicine 18:2775-2794.
13. Nagelkerke, N., Fidler, V., Bernsen, R., Borgdorff, M. (2000). Estimating treatment effects in randomized clinical trials in the presence of non-compliance. Statistics in Medicine 19:1849-1864.
14. Newhouse, J., McClellan, M. (1998). Econometrics in outcomes research: The use of instrumental variables. Annual Review of Public Health 19:17-34.
15. Robins, J. (1998). Correction for non-compliance in equivalence trials. Statistics in Medicine 17:269-302.
16. Robins, J., Greenland, S. (1996). Comment in Journal of the American Statistical Association 91:456-458.
17. Scheiner, L., Rubin, D. (1995). Intention-to-treat analysis and the goals of clinical trials. Clinical Pharmacology and Therapeutics 57:6-15.
18. Sheng, D., Kim, M. (2006). The effects of non-compliance on intent-to-treat analysis of equivalence trials. Statistics in Medicine 25:1183-1199.
19. White, I. (2005). Uses and limitations of randomization-based efficacy estimators. Statistical Methods in Medical Research 4:327-347.